Aerpio Pharmaceuticals, Inc.
Aerpio Pharmaceuticals, Inc. (ARPO) Stock Ownership
Latest 13F position summary is not yet available — breakdown and tables fill in after filings publish (typically ~45 days after quarter end).
SEC 13F · FMP · ARPO · as of —
Ownership Breakdown
Institutional data for this period is not yet available. SEC Form 13F filings are typically published 45 days after quarter end.
No institutional data available for this period.
Insider Buying vs Selling
ARPO insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Dalal Anupam director | Jun 30, 2021 | Award | 7,400 | $1.52 | $11.2K | 17.0K | Form 4 ↗ |
Castelein Caley director | Jun 30, 2021 | Award | 7,811 | $1.52 | $11.9K | 295.4K | Form 4 ↗ |
Cohen Cheryl director | Jun 30, 2021 | Award | 8,140 | $1.52 | $12.4K | 16.2K | Form 4 ↗ |
Cohen Cheryl director | Jun 17, 2021 | Award | 100,000 | $1.87 | $187.0K | 100.0K | Form 4 ↗ |
Cohen Cheryl director | Mar 31, 2021 | Award | 8,020 | $1.54 | $12.4K | 8.0K | Form 4 ↗ |
Dalal Anupam director | Mar 31, 2021 | Award | 7,290 | $1.54 | $11.2K | 9.6K | Form 4 ↗ |
Castelein Caley director | Mar 31, 2021 | Award | 7,696 | $1.54 | $11.9K | 287.6K | Form 4 ↗ |
Cohen Cheryl director | Feb 1, 2021 | Award | 17,857 | $1.46 | $26.1K | 17.9K | Form 4 ↗ |
Castelein Caley director | Feb 1, 2021 | Award | 17,857 | $1.46 | $26.1K | 17.9K | Form 4 ↗ |
Dalal Anupam director | Feb 1, 2021 | Award | 17,857 | $1.46 | $26.1K | 17.9K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Aerpio Pharmaceuticals, Inc. (ARPO) is primarily owned by institutional investors, who hold approximately — of total shares outstanding. Company insiders own approximately —, while retail and public investors account for the remaining —.
A total of 0 institutional investors currently hold ARPO stock, with a combined institutional value of approximately $0 as of the most recent 13F filing period.
Frequently asked questions
ARPO ownershipAerpio Pharmaceuticals, Inc. (ARPO) is primarily owned by institutional investors, who hold approximately — of shares. The largest shareholder is — with a — stake. Company insiders hold —. Data sourced from SEC Form 13F as of —.